The choice of excipients and optimization of the composition of orally disintegrating tablets based on paracetamol and N-acetyl-D-glucosamine
Keywords:paracetamol; N-acetyl-D-glucosamine; povidone; copovidone; crospovidone; mathematical prediction; orally disintegrating tablets
Aim. The choice of the qualitative and quantitative composition of excipients to provide the required mechanical strength and disintegration time when developing a pharmaceutical composition in the form of orally disintegrating tablets (ODT) based on paracetamol and N-acetyl-D-glucosamine.
Materials and methods. The study object was pharmaceutically accepted excipients used in the pharmaceutical development of solid dosage forms. To conduct the statistical analysis of experimental data, a Minitab® 19.1.1 software was used.
Results and discussion. The excipients (povidone of different brands, copovidone, crospovidone of different brands, croscarmellose) used when developing ODT were considered, and it was determined that copovidone and crospovidone type A showed the most optimal quality indicators of the composition. It was found that the particle size
of crospovidone and the route of its introduction affected the rate of disintegration in the aqueous medium. Using the method of mathematical prediction the optimal content of excipients in the composition and the experimental confirmation of
the quality indicators of the mixture selected to create ODT were determined.
Conclusions. Excipients used in the development of ODT have been considered, and the excipients exhibiting the best quality indicators of the compositions have been found. Both the influence of the particle size of crospovidone, and the route of its administration have been determined. The optimal content of excipients in the composition and their experimental confirmation have been determined due to mathematical prediction.
Зупанець І. В., Рубан О. А., Колісник Т. Є. Сучасний стан розробки таблеток, що розпадаються у ротовій порожнині. Український біофармацевтичний журнал. 2019. № 3. С. 6–12. DOI: https://doi.org/10.24959/170227.
Дослідження асортименту допоміжних речовин, які використовують у лікарських засобах, зареєстрованих на території України / О. І. Лукашів та ін. Фармацевтичний часопис. 2013. № 3. С. 50–54. DOI: https://doi.org/10.11603/2312-0967.2013.3.2417.
Державний реєстр лікарських засобів України. URL: http://www.drlz.com.ua/.
Kurakula M., Koteswara Rao G. S. N. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition. Journal of Drug Delivery Science and Technology. 2020. № 60. С. 1–24. DOI: https://doi.org/10.1016/j.jddst.2020.102046.
Polyvinylpyrrolidone (PVP) in nanoparticle synthesis / K. Koczkur et al. Dalton Transactions. 2015. № 44. Р. 17883–17905. DOI: https://doi.org/10.1039/C5DT02964C.
Wlodarski K., Tajber L., Sawicki W. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA. European Journal of Pharmaceutics and Biopharmaceutics. 2016. № 109. Р. 14–23. DOI: https:// doi.org/10.1016/j.ejpb.2016.09.011.
Исследование влияния размера частиц кросповидона на характеристики таблеток с разными составами ядер / Т. Агнезе и др. Фармацевтическая отрасль. 2017. № 5 (64). С. 64–67.
Insoluble Kollidon® grades : technical information. BASF – Nutrition & Health. 2019. 13 р.
Parfati N., Citra Rani K. The effects of croscarmellose sodium concentration on the physicochemical characteristics of orodispersible tablets of atenolol. PharmaСiana. 2018. Vol. 8, № 1. Р. 87–95. DOI: https://doi.org/10.12928/pharmaciana.v8i1.7619.
Guidance for Industry Orally Disintegrating Tablets / U.S. Department of Health and Human Services Food and Drug Administration. 2008. URL: https://www.fda.gov/media/70877/download.
Pabari R., Ramtoola Z. Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets. Journal of Young Pharmacists. 2012. Vol. 3, Iss. 4. P. 157–163. DOI: https://doi.org/10.4103/0975-1483.100021.
Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets / M. Sotoyama et al. Biological and Pharmaceutical Bulletin. 2017. Vol. 40, Iss. 4. P. 451–457. DOI: https://doi.org/10.1248/bpb.b16-00828.
Zupanets I., Ruban О., Kolisnyk T. Choosing the Type and Amount of Sweetener in ODT Formulation by Two Methods of Taste Assessment. Proceedings of the Joint International Pharmacy Symposium “Contemporary pharmacy: issues challenges and expectations 2021“ and “11th Conference: pharmacy science and practice“. Kaunas, Lithuania, 2021. P. 46.
Copyright (c) 2022 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).